This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Gemoscan Canada, Inc.: 'Weighing' In On The Obesity Epidemic In Canada Following The American Medical Association's Designation Of Obesity As An Official 'Disease'

TORONTO, June 24, 2013 (GLOBE NEWSWIRE) -- Gemoscan Canada, Inc. (TSX-V:GES) (MUN:1GE) ("Gemoscan" or the "Company") agrees that Obesity continues to be a 'hot topic' and applauds the recent designation by the American Medical Association (AMA) to classify obesity as an official disease ensuring this heavily debated discussion isn't going away anytime soon. Over 25 per cent of Canadian adults are overweight and rates among children are at an all time high according to a recent study conducted by the University of British Columbia, signaling the need for continued action and new approaches to manage this escalating problem - which may include one that is often overlooked, the role of food intolerances.

Canadians are bombarded with a repetitive list of steps to manage an expanding waistline, these include the standard measures - regular exercise, eating healthier foods and in some cases even surgery, but there is research to suggest that understanding an individuals food interactions can be an important factor that facilitates weight loss.

A 2012 study conducted by the University of Miami Miller School of Medicine, concluded "eliminating foods that are reactive, while replacing them with similar, non-reactive foods to ensure that nutrient deficiencies do not occur, is a novel strategy for addressing the epidemic of obesity."

"Yesterday's announcement by the AMA finally legitimizes the extent of the obesity problem which is responsible for so many co-morbidities and deaths in Canada and the US," says Dr. Mubina Jiwa, ND, Assistant Professor at the Canadian College of Naturopathic Medicine and Chief Naturopathic Doctor - Gemoscan Canada, Inc. "This is a problem that needs to be looked at as a 'whole' and a variety of approaches need to be considered. I work with many patients who are battling obesity and one effective tool I employ is a proven method for food intolerance management."

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs